{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:55:45Z","timestamp":1785455745280,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501388"],"award-info":[{"award-number":["81501388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ17H160007"],"award-info":[{"award-number":["LQ17H160007"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY20H100007"],"award-info":[{"award-number":["LY20H100007"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["No.LY20H100007"],"award-info":[{"award-number":["No.LY20H100007"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["2015C33177"],"award-info":[{"award-number":["2015C33177"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["2017C33032"],"award-info":[{"award-number":["2017C33032"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.rmed.2020.105948","type":"journal-article","created":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T11:31:48Z","timestamp":1585395108000},"page":"105948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Increased serum soluble programmed death ligand 1(sPD-L1) is associated with the presence of interstitial lung disease in rheumatoid arthritis: A monocentric cross-sectional study"],"prefix":"10.1016","volume":"166","author":[{"given":"Xinyu","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songzhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.rmed.2020.105948_bib1","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJM199005033221805","article-title":"Rheumatoid arthritis. Pathophysiology and implications for therapy","volume":"322","author":"Harris","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.rmed.2020.105948_bib2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3904\/kjim.2016.098","article-title":"Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis","volume":"31","author":"Kim","year":"2016","journal-title":"Kor. J. Int. Med."},{"issue":"9","key":"10.1016\/j.rmed.2020.105948_bib3","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"N. British Rheumatoid Interstitial Lung, Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.rmed.2020.105948_bib4","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.rmed.2020.105948_bib5","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.09-0444","article-title":"Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"issue":"7637","key":"10.1016\/j.rmed.2020.105948_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.rmed.2020.105948_bib7","first-page":"728","article-title":"Programmed cell death protein-1\/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role","volume":"4","author":"Santarpia","year":"2015","journal-title":"Transl. Lung Cancer Res."},{"issue":"57","key":"10.1016\/j.rmed.2020.105948_bib8","doi-asserted-by":"crossref","first-page":"97671","DOI":"10.18632\/oncotarget.18311","article-title":"Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.rmed.2020.105948_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2016.08.001","article-title":"Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib","volume":"100","author":"Sorensen","year":"2016","journal-title":"Lung Canc."},{"key":"10.1016\/j.rmed.2020.105948_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2016.11.023","article-title":"High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer","volume":"104","author":"Okuma","year":"2017","journal-title":"Lung Canc."},{"issue":"5","key":"10.1016\/j.rmed.2020.105948_bib11","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.immuni.2016.04.017","article-title":"Co-stimulatory and Co-inhibitory pathways in autoimmunity","volume":"44","author":"Zhang","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.rmed.2020.105948_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cellimm.2014.05.006","article-title":"The PD-1\/PD-Ls pathway and autoimmune diseases","volume":"290","author":"Dai","year":"2014","journal-title":"Cell. Immunol."},{"issue":"12","key":"10.1016\/j.rmed.2020.105948_bib13","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.21037\/jtd.2018.11.16","article-title":"Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis-a pilot study","volume":"10","author":"Jovanovic","year":"2018","journal-title":"J. Thorac. Dis."},{"issue":"3","key":"10.1016\/j.rmed.2020.105948_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.rmed.2020.105948_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1148\/radiol.2373041515","article-title":"Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 cases","volume":"238","author":"Ichikado","year":"2006","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.rmed.2020.105948_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/ard.61.6.517","article-title":"Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis","volume":"61","author":"Dawson","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.rmed.2020.105948_bib17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/rheumatology\/keq426","article-title":"Patients with limited rheumatoid arthritis-related interstitial lung disease have a better prognosis than those with extensive disease","volume":"50","author":"Sathi","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.rmed.2020.105948_bib18","first-page":"68","article-title":"New serum indicator of interstitial pneumonitis activity","volume":"96","author":"Kohno","year":"1989","journal-title":"Sialylated carbohydrate antigen KL-6, Chest"},{"issue":"5 Pt 1","key":"10.1016\/j.rmed.2020.105948_bib19","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1164\/ajrccm.158.5.9803115","article-title":"Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis","volume":"158","author":"Yokoyama","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2020.105948_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/PL00007584","article-title":"Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin","volume":"175","author":"Oyama","year":"1997","journal-title":"Lung"},{"issue":"13","key":"10.1016\/j.rmed.2020.105948_bib21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/jama.1968.03140260033015","article-title":"Serum lactic dehydrogenase activity and diffuse interstitial pneumonitis","volume":"204","author":"DeRemee","year":"1968","journal-title":"J. Am. Med. Assoc."},{"issue":"8","key":"10.1016\/j.rmed.2020.105948_bib22","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2020.105948_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.2006.052506","article-title":"Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis","volume":"66","author":"Turesson","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.rmed.2020.105948_bib24","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.rmed.2020.105948_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.rmed.2020.105948_bib26","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3899\/jrheum.161480","article-title":"Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies","volume":"44","author":"Shi","year":"2017","journal-title":"J. Rheumatol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120300883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120300883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:15:09Z","timestamp":1778778909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611120300883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":26,"alternative-id":["S0954611120300883"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2020.105948","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased serum soluble programmed death ligand 1(sPD-L1) is associated with the presence of interstitial lung disease in rheumatoid arthritis: A monocentric cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2020.105948","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105948"}}